Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimers Disease
NEJM 355:1525-1538,1604, Schneider,L.S.,et al, 2006
Acute Necrotizing Encephalopathy of Childhood: Correlation of MR Findings and Clinical Outcome
AJNR 27:1919-1923, Wong,A.M.,et al, 2006
Seizures During Stroke Thrombolysis Heralding Dramatic Neurologic Recovery
Neurol 67:2048-2049, Rodan,L.H.,et al, 2006
Ischaemic Stroke With Malignancy May Often Be Caused by Paradoxical Embolism
JNNP 77:1336-1339, Iguchi,Y.,et al, 2006
Self-Monitoring of Oral Anticoagulation: A Systematic Review and Meta-Analysis
Lancet 367:404-411,412, Heneghan,C.,et al, 2006
Sudden Unexpected Death in Epilepsy (SUDEP): Dont Ask, Dont Tell?
JNNP 77:199-202, Morton,B.,et al, 2006
Classification and Pathogenesis of Cerebral Hemorrhages After Thrombolysis in Ischemic Stroke
Stroke 37:556-561, Trouillas,P. &von Kummer,R., 2006
Factors Associated With In-Hospital Mortality After Administration of Thrombolysis in Acute Ischemic Stroke Patients, An Analysis of the Nationwide Inpatient Sample 1999 to 2002
Stroke 37:440-446, Bateman,B.T.,et al, 2006
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 37:577-617, Sacco,R.L.,et al, 2006
Chronic Daily Headache
NEJM 354:158-165, Dodick,D.W., 2006
American Academy of Neurology Qualifications and Guidelines for the Physician Expert Witness
Neurol 66:13-14,1, Williams,M.A.,et al, 2006
Suicide After Deep Brain Stimulation of the Internal Globus Pallidus for Dystonia
Neurol 66:142-143, Foncke,E.M.J.,et al, 2006
Perfusion CT Helps Decision Making for Thrombolysis When There is No Clear Time of Onset
JNNP 77:417-419, Hellier,K.D.,et al, 2006
Thrombolysis for Acute Stroke with Special Emphasis on the Very Old:Experience From a Single Dutch Centre
JNNP 77:375-377,288, van Oostenbrugge,R.J.,et al, 2006
The First Seizure and Its Management in Adults and Children
BMJ 332:339-342, Pohlmann-Eden,B.,et al, 2006
Standardized MR Imaging Protocol for Multiple Sclerosis:Consortium of MS Centers Consensus Guidelines
AJNR 27:455-461, Simon,J.H.,et al, 2006
Hyperostosis Frontalis Interna
Arch Neurol 63:291, Waclawik,A.J., 2006
Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients
Stroke 37:852-858, Thomalla,G.,et al, 2006
Role of CT Angiography in Thrombolysis Decision-Making for Patients with Presumed Seizure at Stroke Onset
Stroke 37:915-917, Sylaja,P.N.,et al, 2006
Thrombolytic Therapy of Acute Ischemic Stroke During Pregnancy
Neurol 66:768-770, Murugappan,A.,et al, 2006
Imaging-Guided Acute Ischemic Stroke Therapy: From "Time is Brain" to "Physiology is Brain"
AJNR 27:728-735, Gonzalez,R.G., 2006
Practice Parameter: Evaluation and Treatment of Depression, Psychosis, and Dementia in Parkinson Disease (An Evidence-Based Review)
Neurol 66:996-1002, Miyasaki,J.M.,et al, 2006
Practice Parameter: Treatment of Parkinson Disease with Motor Fluctuations and Dyskinesia (An Evidence-Based Review)
Neurol 66:983-995, Pahwa,R.,et al, 2006
Practice Parameter: Diagnosis and Prognosis of New Onset Parkinson Disease (An Evidence-Based Review)
Neurol 66:968-975, Suchowersky,O.,et al, 2006
Adult Epilepsy
Lancet 367:1087-1100, Duncan,J.S.,et al, 2006
Practice Parameter: Neuroprotective Strategies and Alternative Therapies for Parkinson Disease (An Evidence-Based Review)
Neurol 66:976-982, Suchowersky,O.,et al, 2006
Chronic Disorders of Consciousness
Lancet 367:1181-1192, Bernat,J.L., 2006
Poststroke C-Reactive Protein Is a Powerful Prognostic Tool Among Candidates for Thrombolysis
Stroke 37:1205-1210, Montaner,J.,et al, 2006
Corticosteroids in Patients With Hemorrhagic Stroke
Stroke 37:1344-1345, Feigin,V.L.,et al, 2006
Good Outcomes in Ischemic Stroke Patients treated With Intravenous Thrombolysis Despite Regressing Neurological Symptoms
Stroke 37:1332-1333, Baumann,C.R.,et al, 2006
Reasons Why Few Patients With Acute Stroke Receive Tissue Plasminogen Activator
Arch Neurol 63:661-664, Bambauer,K.Z.,et al, 2006
Primary Prevention of Ischemic Stroke
Stroke 37:1583-1633, Goldstein,L.B.,et al, 2006
Clinicopath Conf, Acute Ischemic Stroke
NEJM 354:2263-2271, Case 16:2006, 2006
Community Socioeconomic Status and Prehospital Times in Acute Stroke and Transient Ischemic Attack
Stroke 37:1508-1513,1354, Kleindorfer,D.O.,et al, 2006
Thrombolysis in Patients Older Than 80 Years With Acute Ischaemic Stroke: Canadian Alteplase for Stroke Effectiveness Study
JNNP 77:826-829,812, Sylaja, P.N.,et al, 2006
Thrombolysis (Tissue Plasminogen Activator) in Stroke: A Medicolegal Quagmire
Stroke 37:1917-1922, Weintraub,M.I., 2006
Practice Parameter: Prediction of Outcome in Comatose Survivors After Cardiopulmonary Resuscitation (An Evidence-Based Review).
Neurol 67:203-210, Wijdicks,E.F.M.,et al, 2006
Diagnosis and Treatment of low Back Pain
BMJ 332:1430-1434, Koes,B.W.,et al, 2006
Carotid Artery Stenting: First Consensus Document of the ICCS-SPREAD Joint Committee
Stroke 37:2400-2409, Cremonesi,A.,et al, 2006
Using the Baseline CT Scan to Select Acute Stroke Patients for IV-IA Therapy
AJNR 27:1612-1616, Hill,M.E.,et al, 2006
National Stroke Association Guidelines for the Management of Transient Ischemic Attacks
Ann Neurol 60:301-313,273, Johnston,S.C.,et al, 2006
Leukoaraiosis Is a Risk Factor for Symptomatic Intracerebral Hemorrhage After Thrombolysis for Acute Stroke
Stroke 37:2463-2466, Neumann-Haefelin,T.,et al, 2006
The Tuberous Sclerosis Complex
NEJM 355:1345-1356, Crino,P.B.,et al, 2006
Should a Patient With Primary Intracerebral Haemorrhage Receive Antiplatelet or Anticoagulant Therapy?
BMJ 331:439-442, Wani,M.,et al, 2005
Diagnosis and Initial Management of Parkinsons Disease
NEJM 353:1021-1027, Nutt,J.G.&Wooten,G.F., 2005
Use of Serum Prolactin in Diagnosing Epileptic Seizures
Neurol 65:668-675, Chen,D.K.,et al, 2005
Carotid Endarterectomy-An Evidence-Based Review
Neurol 65:794-801, Chaturvedi,S.,et al, 2005
Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke
Stroke 36:1316-1329, Di Napoli,M.,et al, 2005
Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke
Stroke 36:2497-2499, Smith,E.E.,et al, 2005
Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (=80 Years) Stroke Patients
Stroke 36:2421-2425, Berrouschot,J.,et al, 2005